查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1418355

奈米抗體市場報告：2030 年趨勢、預測與競爭分析

Nanobody Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

奈米抗體趨勢和預測

到 2030 年，全球奈米抗體市場預計將達到 28 億美元，2024 年至 2030 年複合年成長率為 24.7%。該市場的主要驅動力是人們對精準醫療的興趣日益濃厚以及對奈米抗體研發的支持不斷增加。全球奈米抗體市場的未來充滿希望，在治療、診斷和研究市場中充滿機會。

奈米抗體市場洞察

Lucintel 預測，由於不同癌症類型的存在不斷增加，特異性奈米抗體預計將在預測期內出現強勁成長。

在這個市場中，由於製藥公司擴大採用奈米抗體，研究仍然是最大的部分。

由於對奈米抗體技術的高度認知，北美在預測期內仍然是最大的地區。

常問問題

Q1.市場規模有多大？

A1. 到 2030 年，全球奈米抗體市場預計將達到 28 億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球奈米抗體市場預計將以24.7%的複合年成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要促進因素是人們對精準醫療的興趣日益濃厚以及對奈米抗體研發的支持不斷增加。

Q4.市場的主要細分市場是什麼？

A4. 奈米抗體市場的未來是充滿希望的，在治療、診斷和研究市場上都有機會。

Q5. 市場上主要企業有哪些？

A5. 主要奈米抗體公司如下。

  • Sanofi
  • Merck KGaA
  • BIOCYTOGEN
  • Proteintech
  • Novartis
  • GenScript
  • Sensei Biotherapeutics
  • Beroni
  • ExeVir Bio
  • Taisho Pharmaceutical

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於各種癌症的增加，特異性奈米抗體將在預測期內出現強勁成長。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 由於對奈米抗體技術的高度認知，北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球奈米抗體市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球奈米抗體市場趨勢（2018-2023）與預測（2024-2030）
  • 按類型
    • 單一特異性
    • 多麼具體的
  • 按用途
    • 治療性的
    • 診斷
    • 調查
  • 按最終用途
    • 製藥和生物技術公司
    • 調查
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的奈米抗體市場
  • 北美洲奈米抗體市場
  • 歐洲奈米抗體市場
  • 亞太奈米抗體市場
  • 其他地區奈米抗體市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球奈米抗體市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球奈米抗體市場容量
    • 全球奈米抗體市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Sanofi
  • Merck KGaA
  • BIOCYTOGEN
  • Proteintech
  • Novartis
  • GenScript
  • Sensei Biotherapeutics
  • Beroni
  • ExeVir Bio
  • Taisho Pharmaceutical
簡介目錄

Nanobody Trends and Forecast

The future of the global nanobody market looks promising with opportunities in the therapeutic, diagnostic, and research markets. The global nanobody market is expected to reach an estimated $2.8 billion by 2030 with a CAGR of 24.7% from 2024 to 2030. The major drivers for this market are surging interest in precision medicine and elevating support for nanobody research and development.

A more than 150-page report is developed to help in your business decisions.

Nanobody by Segment

The study includes a forecast for the global nanobody by type, application, end use, and region.

Nanobody Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Mono-Specific
  • Multi-Specific

Nanobody Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Therapeutic
  • Diagnostic
  • Research

Nanobody Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories
  • Others

Nanobody Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Nanobody Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nanobody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nanobody companies profiled in this report include-

  • Sanofi
  • Merck KGaA
  • BIOCYTOGEN
  • Proteintech
  • Novartis
  • GenScript
  • Sensei Biotherapeutics
  • Beroni
  • ExeVir Bio
  • Taisho Pharmaceutical

Nanobody Market Insights

Lucintel forecasts that mono-specific is expected to witness the higher growth over the forecast period due to escalating presence of diverse cancer types.

Within this market, research will remain the largest segment due to growing adoption of nanobodies by pharmaceutical companies.

North America will remain the largest region over the forecast period due to high awareness associated with nanobodies technology.

Features of the Global Nanobody Market

Market Size Estimates: Nanobody market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nanobody market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Nanobody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the nanobody market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nanobody market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the nanobody market size?

Answer: The global nanobody market is expected to reach an estimated $2.8 billion by 2030.

Q2. What is the growth forecast for nanobody market?

Answer: The global nanobody market is expected to grow with a CAGR of 24.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the nanobody market?

Answer: The major drivers for this market are surging interest in precision medicine and elevating support for nanobody research and development.

Q4. What are the major segments for nanobody market?

Answer: The future of the nanobody market looks promising with opportunities in the therapeutic, diagnostic, and research markets.

Q5. Who are the key nanobody market companies?

Answer: Some of the key nanobody companies are as follows.

  • Sanofi
  • Merck KGaA
  • BIOCYTOGEN
  • Proteintech
  • Novartis
  • GenScript
  • Sensei Biotherapeutics
  • Beroni
  • ExeVir Bio
  • Taisho Pharmaceutical

Q6. Which nanobody market segment will be the largest in future?

Answer: Lucintel forecasts that mono-specific is expected to witness the higher growth over the forecast period due to escalating presence of diverse cancer types.

Q7. In nanobody market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high awareness associated with nanobodies technology.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the nanobody market by type (mono-specific and multi-specific), application (therapeutic, diagnostic, and research), end use (pharmaceutical & biotechnology companies, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nanobody Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Nanobody Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Nanobody Market by Type
    • 3.3.1: Mono-Specific
    • 3.3.2: Multi-Specific
  • 3.4: Global Nanobody Market by Application
    • 3.4.1: Therapeutic
    • 3.4.2: Diagnostic
    • 3.4.3: Research
  • 3.5: Global Nanobody Market by End Use
    • 3.5.1: Pharmaceutical & Biotechnology Companies
    • 3.5.2: Research Laboratories
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Nanobody Market by Region
  • 4.2: North American Nanobody Market
    • 4.2.2: North American Nanobody Market by Application: Therapeutic, Diagnostic, and Research
  • 4.3: European Nanobody Market
    • 4.3.1: European Nanobody Market by Type: Mono-Specific and Multi-Specific
    • 4.3.2: European Nanobody Market by Application: Therapeutic, Diagnostic, and Research
  • 4.4: APAC Nanobody Market
    • 4.4.1: APAC Nanobody Market by Type: Mono-Specific and Multi-Specific
    • 4.4.2: APAC Nanobody Market by Application: Therapeutic, Diagnostic, and Research
  • 4.5: ROW Nanobody Market
    • 4.5.1: ROW Nanobody Market by Type: Mono-Specific and Multi-Specific
    • 4.5.2: ROW Nanobody Market by Application: Therapeutic, Diagnostic, and Research

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Nanobody Market by Type
    • 6.1.2: Growth Opportunities for the Global Nanobody Market by Application
    • 6.1.3: Growth Opportunities for the Global Nanobody Market by End Use
    • 6.1.4: Growth Opportunities for the Global Nanobody Market by Region
  • 6.2: Emerging Trends in the Global Nanobody Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Nanobody Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nanobody Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Sanofi
  • 7.2: Merck KGaA
  • 7.3: BIOCYTOGEN
  • 7.4: Proteintech
  • 7.5: Novartis
  • 7.6: GenScript
  • 7.7: Sensei Biotherapeutics
  • 7.8: Beroni
  • 7.9: ExeVir Bio
  • 7.10: Taisho Pharmaceutical